Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy

Background: For patients with alpha-1 antitrypsin (AAT) deficiency, AAT augmentation therapy can be an important part of care. However, for those who require a lung transplant (LT), there is currently only limited information to guide the use of AAT augmentation therapy post-LT. Methods: We identifi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Atharv V. Oak, MEng, Jessica M. Ruck, MD, PhD, Alfred J. Casillan, MD, PhD, Armaan F. Akbar, BS, Ramon A. Riojas, MD, PhD, Pali D. Shah, MD, Jinny S. Ha, MD, MHS, Sara Strout, PharmD, Allan B. Massie, PhD, Dorry L. Segev, MD, PhD, Christian A. Merlo, MD, MPH, Errol L. Bush, MD
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2025-02-01
Edice:	JHLT Open
Témata:	alpha-1 antitrypsin emphysema lung transplant augmentation therapy survival outcomes
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2950133424001514
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!